Following several media reports regarding the substance Actovegin, there has been a high level of interest on what the status of Actovegin is in sport.
To help clarify any confusion, ASADA can confirm that the status of Actovegin has remained the same since the first WADA Prohibited List was published in 2004.
Actovegin is not prohibited in sport under the WADA List of Prohibited Substances and Methods except if it is used by intravenous infusion/injection according to section M2 (Chemical and Physical Manipulation) of the List.
The current M2 wording in the 2015 Prohibited List states that Intravenous infusions and/or injections of more than 50 mL per 6 hour period are prohibited except for those legitimately received in the course of hospital admissions, surgical procedures or clinical investigations.
Actovegin is a deproteinized ultrafiltrate of calf serum and does not contain blood cells susceptible to increase oxygen transport. It was tested by anti-doping laboratories and no prohibited substances were found.